Literature DB >> 20861473

Hypoxic preconditioning induces the expression of prosurvival and proangiogenic markers in mesenchymal stem cells.

Simi M Chacko1, Shabnam Ahmed, Karuppaiyah Selvendiran, M Lakshmi Kuppusamy, Mahmood Khan, Periannan Kuppusamy.   

Abstract

Stem cells transplanted to the ischemic myocardium usually encounter massive cell death within a few days of therapy. Hypoxic preconditioning (HPC) is currently employed as a strategy to prepare stem cells for increased survival and engraftment in the heart. However, HPC of stem cells has provided varying results, supposedly due to the differences in the oxygen concentration, duration of exposure, and passage conditions. In the present study, we determined the effect of HPC on rat mesenchymal stem cells (MSCs) exposed to 0.5% oxygen concentration for 24, 48, or 72 h. We evaluated the expression of prosurvival, proangiogenic, and functional markers such as hypoxia-inducible factor-1α, VEGF, phosphorylated Akt, survivin, p21, cytochrome c, caspase-3, caspase-7, CXCR4, and c-Met. MSCs exposed to 24-h hypoxia showed reduced apoptosis on being subjected to severe hypoxic conditions. They also had significantly higher levels of prosurvival, proangiogenic, and prodifferentiation proteins when compared with longer exposure (72 h). Cells taken directly from the cryopreserved state did not respond effectively to the 24-h HPC as those that were cultured under normoxia before HPC. Cells cultured under normoxia before HPC showed decreased apoptosis, enhanced expression of connexin-43, cardiac myosin heavy chain, and CD31. The preconditioned cells were able to differentiate into the cardiovascular lineage. The results suggest that MSCs cultured under normoxia before 24-h HPC are in a state of optimal expression of prosurvival, proangiogenic, and functional proteins that may increase the survival and engraftment in the infarct heart. These results could provide further insights into optimal preparation of MSCs which would greatly influence the effectiveness of cell therapy in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20861473      PMCID: PMC3006322          DOI: 10.1152/ajpcell.00221.2010

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  43 in total

1.  Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: safety, clinical outcome, and serial changes in left ventricular function during 12-months' follow-up.

Authors:  Ketil Lunde; Svein Solheim; Kolbjørn Forfang; Harald Arnesen; Lorentz Brinch; Reidar Bjørnerheim; Asgrimur Ragnarsson; Torstein Egeland; Knut Endresen; Arnfinn Ilebekk; Arild Mangschau; Svend Aakhus
Journal:  J Am Coll Cardiol       Date:  2008-02-12       Impact factor: 24.094

Review 2.  Bone marrow-derived stem/progenitor cells: their use in clinical studies for the treatment of myocardial infarction.

Authors:  Gabriel P Lasala; José J Minguell
Journal:  Heart Lung Circ       Date:  2008-12-09       Impact factor: 2.975

Review 3.  Bone marrow-derived mesenchymal stems cells and cardiac repair.

Authors:  A R Chugh; E K Zuba-Surma; B Dawn
Journal:  Minerva Cardioangiol       Date:  2009-04       Impact factor: 1.347

Review 4.  The role of hypoxia in stem cell differentiation and therapeutics.

Authors:  Hamid Abdollahi; Lisa J Harris; Ping Zhang; Stephen McIlhenny; Vikram Srinivas; Thomas Tulenko; Paul J DiMuzio
Journal:  J Surg Res       Date:  2009-10-24       Impact factor: 2.192

5.  Myocardial oxygenation and functional recovery in infarct rat hearts transplanted with mesenchymal stem cells.

Authors:  Simi M Chacko; Mahmood Khan; M Lakshmi Kuppusamy; Ramasamy P Pandian; Saradhadevi Varadharaj; Karuppaiyah Selvendiran; Anna Bratasz; Brian K Rivera; Periannan Kuppusamy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-03-13       Impact factor: 4.733

Review 6.  The role of hypoxia in bone marrow-derived mesenchymal stem cells: considerations for regenerative medicine approaches.

Authors:  Ruud Das; Holger Jahr; Gerjo J V M van Osch; Eric Farrell
Journal:  Tissue Eng Part B Rev       Date:  2010-04       Impact factor: 6.389

7.  Anoxic preconditioning: a way to enhance the cardioprotection of mesenchymal stem cells.

Authors:  Jian-an Wang; Aina He; Xinyang Hu; Yun Jiang; Yong Sun; Jun Jiang; Chun Gui; Yaping Wang; Han Chen
Journal:  Int J Cardiol       Date:  2008-01-29       Impact factor: 4.164

Review 8.  Regenerative capacity of the myocardium: implications for treatment of heart failure.

Authors:  Rüdiger von Harsdorf; Philip A Poole-Wilson; Rainer Dietz
Journal:  Lancet       Date:  2004-04-17       Impact factor: 79.321

9.  Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells.

Authors:  Warren L Grayson; Feng Zhao; Bruce Bunnell; Teng Ma
Journal:  Biochem Biophys Res Commun       Date:  2007-05-22       Impact factor: 3.575

10.  Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo.

Authors:  Shih-Chieh Hung; Radhika R Pochampally; Shu-Ching Hsu; Cecelia Sanchez; Sy-Chi Chen; Jeffrey Spees; Darwin J Prockop
Journal:  PLoS One       Date:  2007-05-02       Impact factor: 3.240

View more
  85 in total

1.  Vascular morphogenesis of adipose-derived stem cells is mediated by heterotypic cell-cell interactions.

Authors:  Daphne L Hutton; Elizabeth A Logsdon; Erika M Moore; Feilim Mac Gabhann; Jeffrey M Gimble; Warren L Grayson
Journal:  Tissue Eng Part A       Date:  2012-05-09       Impact factor: 3.845

2.  Peroxisome Proliferator-Activated Receptor Gamma Promotes Mesenchymal Stem Cells to Express Connexin43 via the Inhibition of TGF-β1/Smads Signaling in a Rat Model of Myocardial Infarction.

Authors:  Jingying Hou; Lingyun Wang; Jinghui Hou; Tianzhu Guo; Yue Xing; Shaoxin Zheng; Changqing Zhou; Hui Huang; Huibao Long; Tingting Zhong; Quanhua Wu; Jingfeng Wang; Tong Wang
Journal:  Stem Cell Rev Rep       Date:  2015-12       Impact factor: 5.739

3.  Cardioprotection by PI3K-mediated signaling is required for anti-arrhythmia and myocardial repair in response to ischemic preconditioning in infarcted pig hearts.

Authors:  Feng Su; Lan Zhao; Shaoheng Zhang; Jiahong Wang; Nannan Chen; Qunlin Gong; Jinhui Tang; Hao Wang; Jianhua Yao; Qin Wang; Ming Zhong; Jian Yan
Journal:  Lab Invest       Date:  2015-06-01       Impact factor: 5.662

Review 4.  Can the outcomes of mesenchymal stem cell-based therapy for myocardial infarction be improved? Providing weapons and armour to cells.

Authors:  Andrey A Karpov; Daria V Udalova; Michael G Pliss; Michael M Galagudza
Journal:  Cell Prolif       Date:  2016-11-23       Impact factor: 6.831

5.  Combining adult stem cells and olfactory ensheathing cells: the secretome effect.

Authors:  Nuno A Silva; Jeffrey M Gimble; Nuno Sousa; Rui L Reis; António J Salgado
Journal:  Stem Cells Dev       Date:  2013-01-14       Impact factor: 3.272

6.  Mesenchymal stromal cell characteristics vary depending on their origin.

Authors:  Heike Wegmeyer; Ann-Marie Bröske; Mathias Leddin; Karin Kuentzer; Anna Katharina Nisslbeck; Julia Hupfeld; Kornelius Wiechmann; Jennifer Kuhlen; Christoffer von Schwerin; Carsten Stein; Saskia Knothe; Jürgen Funk; Ralf Huss; Markus Neubauer
Journal:  Stem Cells Dev       Date:  2013-06-22       Impact factor: 3.272

7.  Expansion and angiogenic potential of mesenchymal stem cells from patients with critical limb ischemia.

Authors:  Luke Brewster; Scott Robinson; Ruoya Wang; Sarah Griffiths; Haiyan Li; Alexandra Peister; Ian Copland; Todd McDevitt
Journal:  J Vasc Surg       Date:  2016-02-24       Impact factor: 4.268

Review 8.  Anti-inflammatory strategies in cartilage repair.

Authors:  Ying Zhang; Tyler Pizzute; Ming Pei
Journal:  Tissue Eng Part B Rev       Date:  2014-06-23       Impact factor: 6.389

9.  The early activation of PI3K strongly enhances the resistance of cortical neurons to hypoxic injury via the activation of downstream targets of the PI3K pathway and the normalization of the levels of PARP activity, ATP, and NAD⁺.

Authors:  Min Young Noh; Young Seo Kim; Kyu-Yong Lee; Young Joo Lee; Seung H Kim; Hyun-Jeung Yu; Seong-Ho Koh
Journal:  Mol Neurobiol       Date:  2012-12-20       Impact factor: 5.590

10.  MicroRNAs in cardiovascular disease.

Authors:  Terry S Elton; Mahmood Khan; Dmitry Terentyev
Journal:  F1000 Med Rep       Date:  2011-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.